359 reports of this reaction
3.7% of all NUSINERSEN reports
#4 most reported adverse reaction
PROCEDURAL PAIN is the #4 most commonly reported adverse reaction for NUSINERSEN. There are 359 FDA adverse event reports linking NUSINERSEN to PROCEDURAL PAIN. This represents approximately 3.7% of all 9,682 adverse event reports for this drug.
Patients taking NUSINERSEN who experience procedural pain should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PROCEDURAL PAIN is moderately reported among NUSINERSEN users, representing a notable but not dominant share of adverse events.
In addition to procedural pain, the following adverse reactions have been reported for NUSINERSEN:
The following drugs have also been linked to procedural pain in FDA adverse event reports:
PROCEDURAL PAIN has been reported as an adverse event in 359 FDA reports for NUSINERSEN. This does not prove causation, but indicates an association observed in post-market surveillance data.
PROCEDURAL PAIN accounts for approximately 3.7% of all adverse event reports for NUSINERSEN, making it a notable side effect.
If you experience procedural pain while taking NUSINERSEN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.